Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
Activité liée au VIH dans 24 sites hospitaliers de France métropolitaine en 1995-1996 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Anxiety Increases The Willingness To Be Exposed To Covid-19 Risk Among Young Adults In France |
0 |
0 |
0 |
6 |
1 |
1 |
2 |
32 |
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France |
0 |
0 |
0 |
2 |
1 |
2 |
2 |
18 |
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
16 |
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
8 |
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave |
0 |
0 |
0 |
4 |
0 |
0 |
2 |
4 |
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave |
0 |
0 |
0 |
3 |
0 |
0 |
2 |
3 |
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? |
0 |
0 |
1 |
28 |
0 |
0 |
1 |
234 |
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? |
0 |
0 |
0 |
1 |
1 |
2 |
2 |
44 |
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
16 |
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
13 |
Assurance maladie: la gestion du risque long |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
997 |
Cannabis: comment reprendre le contrôle ? |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
22 |
Cannabis: comment reprendre le contrôle ? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
Changing time and emotions |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
9 |
Changing time and emotions |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
Changing time and emotions |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
Changing time and emotions |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
43 |
Child health and access to health care in France: Evidence on the role of family income |
0 |
0 |
0 |
0 |
1 |
2 |
3 |
7 |
Child health and access to health care in France: Evidence on the role of family income |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
5 |
Child health and use of health care services in France: Evidence on the role of family income |
0 |
0 |
0 |
19 |
2 |
3 |
4 |
21 |
Child health and use of health care services in France: Evidence on the role of family income |
0 |
0 |
1 |
40 |
0 |
1 |
4 |
68 |
Comment analyser le fonctionnement des systèmes de santé ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
13 |
Comment lutter contre les inégalités de santé ? |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
18 |
Comment meurt une épidémie ? La fin du sida en débat |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
14 |
Comment meurt une épidémie ? La fin du sida en débat |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
24 |
Comportements sexuels risques et incitations: l'impact des nouveaux traitements sur la prevention du VIH |
0 |
0 |
0 |
42 |
1 |
1 |
2 |
676 |
Concurrence en santé: marché des soins, marché de l'assurance |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
11 |
Concurrence en santé: marché des soins, marché de l'assurance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France |
0 |
0 |
0 |
9 |
0 |
1 |
1 |
5 |
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
29 |
Data MArkets and OPtimal Sample Size Determination |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
2,834 |
Decomposition of Bivariate Inequality Indicesby Attributes |
0 |
0 |
1 |
56 |
0 |
0 |
2 |
195 |
Decomposition of bivariate inequality indices by attributes |
0 |
0 |
0 |
12 |
0 |
0 |
0 |
69 |
Decomposition of bivariate inequality indices by attributes |
0 |
0 |
0 |
1 |
1 |
1 |
2 |
10 |
Decomposition of bivariate inequality indices by attributes |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
17 |
Decomposition of bivariate inequality indices by attributes |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
30 |
Discouting and Optimizing Capital Accumulation as a Variational Minmax Problem |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
279 |
Disease Eradication: Private vs. Public Vaccination |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
565 |
Dépenses de santé: l'hypothèse d'aléa moral |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
623 |
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
34 |
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
12 |
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported |
0 |
0 |
0 |
1 |
1 |
2 |
4 |
26 |
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
80 |
Family income and child health in the UK |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
13 |
Family income and child health in the UK |
0 |
0 |
1 |
40 |
0 |
1 |
3 |
96 |
Family income and child health in the UK |
0 |
0 |
0 |
3 |
0 |
1 |
1 |
24 |
Family income and child health in the UK |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
15 |
Gérer le risque de dépendance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Gérer le risque de dépendance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
Incentive and Selection Effects in Health Insurance |
0 |
0 |
0 |
0 |
0 |
3 |
3 |
27 |
L'économie du reste à charge |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
L'économie du reste à charge |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
15 |
L'équité dans le financement du système d'indemnisation: quelques éléments de réflexion, beaucoup d'incertitudes |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
La concurrence, c'est l'innovation ? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
20 |
La concurrence, c'est l'innovation ? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
6 |
La demande de prévention est-elle induite par l'offre ? |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
15 |
La demande de prévention est-elle induite par l'offre ? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
17 |
La demande de prévention est-elle induite par l'offre ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
La lancinante réforme de l'assurance maladie |
0 |
0 |
0 |
0 |
1 |
2 |
8 |
50 |
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
1 |
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis |
0 |
1 |
1 |
2 |
0 |
1 |
3 |
4 |
La régulation des dépenses de santé: comment faire ? |
0 |
0 |
0 |
0 |
0 |
3 |
3 |
11 |
La régulation des dépenses de santé: comment faire ? |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
8 |
La régulation des secteurs de la santé: volume 6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
La régulation des secteurs de la santé: volume 6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
25 |
La régulation des secteurs de la santé: volume 6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
La santé par quels moyens et à quels prix ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
30 |
La santé par quels moyens et à quels prix ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
La santé, par quels moyens et à quels prix ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
La santé, par quels moyens et à quels prix ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance |
0 |
0 |
0 |
1 |
0 |
1 |
2 |
21 |
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance |
0 |
0 |
1 |
3 |
0 |
1 |
2 |
37 |
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance |
0 |
0 |
0 |
1 |
0 |
1 |
3 |
12 |
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance |
0 |
0 |
1 |
1 |
1 |
2 |
3 |
17 |
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
11 |
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
Measuring Well Being Inequality |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10 |
Measuring Well Being Inequality |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
4 |
Medical Spending in France: Concentration, Persistence and Evolution before Death |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
25 |
Medical Spending in France: Concentration, Persistence and Evolution before Death |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
8 |
Moral Hazard and the Demand for Physician Services: First Lessons from a French Natural Experiment |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2,155 |
Parents' education and child body weight in France: The trajectory of the gradient in the early years |
0 |
0 |
1 |
27 |
0 |
2 |
4 |
13 |
Parents' education and child body weight in France: The trajectory of the gradient in the early years |
0 |
0 |
1 |
20 |
0 |
1 |
2 |
69 |
Parents' education and child body weight in France: The trajectory of the gradient in the early years |
0 |
0 |
0 |
22 |
0 |
2 |
8 |
85 |
Parents’ education and child body weight in France: The trajectory of the gradient in the early years |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
13 |
Parents’ education and child body weight in France: The trajectory of the gradient in the early years |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
19 |
Peut-on evaluer le cout d'une maladie? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
273 |
Politique de santé et inégalités sociales |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
19 |
Politique de santé et inégalités sociales |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
Politiques de santé en Europe et inégalités sociales |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
13 |
Politiques de santé et inégalités sociales en Europe |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
12 |
Pour un système de santé plus efficace |
0 |
0 |
0 |
31 |
0 |
0 |
5 |
87 |
Pour un système de santé plus efficace |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
22 |
Pricing and R&D with Related Margins |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
562 |
Quelle assurance contre le risque dépendance ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
Quelle assurance contre le risque dépendance ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
Quelles formes de concurrence en assurance santé ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
28 |
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
13 |
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
Rational Epidemics and their Public Control |
0 |
0 |
0 |
0 |
1 |
2 |
8 |
630 |
Refonder l'assurance-maladie |
0 |
0 |
0 |
10 |
0 |
0 |
2 |
48 |
Refonder l’assurance-maladie |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
22 |
Refonder l’assurance-maladie |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
7 |
Reforming Incentive Schemes Under Political Constraints: The Physician Agency |
0 |
0 |
0 |
103 |
0 |
0 |
0 |
406 |
Reforming incentive schemes under political constraints: The physician agency |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
55 |
Reforming incentive schemes under political constraints: The physician agency |
0 |
0 |
0 |
91 |
0 |
0 |
0 |
300 |
Reforming incentive schemes under political contraints: The physician agency |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
17 |
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
9 |
Santé: l'heure des choix |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
Santé: l'heure des choix |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
30 |
Scared by Foreigners and their Products? Survey Evidence from France |
0 |
0 |
0 |
68 |
0 |
0 |
0 |
355 |
Separating Selection and Incentive Effects in Health Insurance |
0 |
0 |
0 |
142 |
0 |
0 |
0 |
429 |
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
46 |
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data |
0 |
0 |
4 |
314 |
1 |
1 |
6 |
1,074 |
Separating selection and incentive effects in health insurance |
0 |
0 |
0 |
6 |
0 |
0 |
1 |
31 |
Separating selection and incentive effects in health insurance |
0 |
0 |
3 |
30 |
0 |
0 |
8 |
120 |
Sunspot Fluctuations around a Steady State: The Case of Multidimensional One-Step forward Looking Economic Models |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
378 |
The Transmission of Information through Prices: an Alternative Exploratory Assessment of Market Performance |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
245 |
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
35 |
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data |
0 |
0 |
0 |
12 |
0 |
0 |
2 |
152 |
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data |
0 |
0 |
0 |
2 |
1 |
1 |
2 |
32 |
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
15 |
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision |
0 |
0 |
0 |
2 |
2 |
2 |
2 |
10 |
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
8 |
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Therapeutic non adherence: A rational behavior revealing patient preferences? |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
7 |
Therapeutic non adherence: A rational behavior revealing patient preferences? |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
46 |
Therapeutic non adherence: a rational behavior revealing patient preferences ? |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
161 |
Therapeutic non adherence: a rational behavior revealing patient preferences ? |
0 |
0 |
0 |
4 |
0 |
1 |
3 |
37 |
Workplace smoking ban effects in an heterogeneous smoking population |
0 |
0 |
0 |
47 |
0 |
0 |
1 |
134 |
Workplace smoking ban effects in an heterogeneous smoking population |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
20 |
Workplace smoking ban effects on unhappy smokers |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
43 |
Workplace smoking ban effects on unhappy smokers |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
À quoi peut servir la concurrence en assurance santé ? |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
53 |
Total Working Papers |
0 |
1 |
17 |
1,277 |
32 |
77 |
202 |
16,175 |